Home
Projects
Posts
Publications
Our Team
Job Opportunities
Contact
Sebastian Szpakowski
Latest
MicroRNA signatures differentiate melanoma subtypes.
Phosphoproteomic screen identifies potential therapeutic targets in melanoma.
MU2A--reconciling the genome and transcriptome to determine the effects of base substitutions.
Using semantic web technologies to annotate and align microarray designs.
Cite
×